专利检索 ap:("Novartis AG" OR "Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.") AND inv:"HAEBERLIN, Barbara" 第 3 页

21.

发明公开
ORGANIC COMPOUNDS COMPRISING A GLYCOPYRROLIUM SALT 审中-公开
标题翻译：含有糖基咔唑盐的有机化合物

公开(公告)号：EP1954266A1

公开(公告)日：2008-08-13

申请号：EP06818679.0

申请日：2006-11-20

申请人： Novartis AG

发明人： COLLINGWOOD, Stephen, Paul , HAEBERLIN, Barbara

IPC分类号： A61K31/40 , A61K31/58 , A61K9/00 , A61P11/06 , A61P11/08

CPC分类号： A61K9/0075 , A61K9/008 , A61K31/40 , A61K31/58 , A61K2300/00

摘要： Medicaments comprising (A) an antimuscarinic agent and (B) a corticosteroid for the treatment of inflammatory or obstructive airways diseases.

摘要翻译： 包含（A）抗毒蕈碱剂和（B）皮质类固醇的药物，用于治疗炎性或阻塞性气道疾病。

22.

发明授权
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION, AUTOIMMUNE OR INFLAMMATORY CONDITIONS COMPRISING CYCLOSPORIN A AND 40-0-(2-HYDROXYETHYL)-RAPAMYCIN 失效
标题翻译：带有锁定对移植物排斥，自身免疫性疾病和炎症WHAT环孢菌素A和40-O-（2-羟基乙基）组合制剂 - 雷帕霉素CONTAINS

公开(公告)号：EP0956034B1

公开(公告)日：2002-08-21

申请号：EP97937526.8

申请日：1997-07-29

申请人： Novartis AG

发明人： ZENKE, Gerhard , SCHUURMAN, Hendrik, J. , HAEBERLIN, Barbara , MEINZER, Armin

IPC分类号： A61K38/13 , A61K31/445 , A61P37/00 , A61P29/00

CPC分类号： A61K31/70 , A61K9/146 , A61K9/4858 , A61K31/445 , A61K31/45 , A61K38/13 , A61K45/06 , A61K2300/00

摘要： A synergistic combination of an IL-2 transcription inhibitor (e.g., cyclosporin A or FK506) and 40-O-(2-hydroxyethyl)-rapamycin is provided, which is useful in the treatment and prevention of transplant rejection and also certain autoimmune and inflammatory diseases, together with novel pharmaceutical compositions comprising an IL-2 transcription inhibitor in combination with a rapamycin, e.g., 40-O-(2-hydroxyethyl)-rapamycin.

23.

发明公开
PHARMACEUTICAL COMPOSITIONS 失效
标题翻译：含微乳液预大环内酯类

公开(公告)号：EP0787011A1

公开(公告)日：1997-08-06

申请号：EP95937005.0

申请日：1995-10-25

申请人： Novartis AG , SANDOZ-PATENT-GMBH , SANDOZ-ERFINDUNGEN Verwaltungsgesellschaft m.b.H.

发明人： COTTENS, Sylvain , HAEBERLIN, Barbara , SEDRANI, Richard , VONDERSCHER, Jacky

IPC分类号： A61K , A61K47 , A61K9 , A61K31 , A61K38 , A61P29 , A61P31 , A61P35 , A61P37

CPC分类号： A61K9/0019 , A61K9/1075 , A61K9/4858 , A61K31/436 , A61K38/13 , A61K47/12

摘要： This invention provides a microemulsion pre-concentrate comprising a difficultly soluble active agent and a carrier medium comprising: 1) a hydrophilic phase which comprises dimethylisosorbide and/or a lower alkyl alkanoic ester, 2) a lipophilic phase, and 3) a surfactant. The active agent may be a cyclosporin or a macrolide. In another aspect, this invention provides a pharmaceutical composition for enteral or parenteral administration comprising a macrolide and an acid.